gene_id,drug_class,notes
EGFR,EGFR inhibitors,Responsive to TKIs (erlotinib/gefitinib)
BRAF,BRAF/MEK inhibitors,Targetable in RAF-driven tumors
ALK,ALK inhibitors,Known fusion/overexpression target
MYC,CDK inhibitors,Indirect targeting strategies
